Review
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 28, 2013; 19(40): 6784-6793
Published online Oct 28, 2013. doi: 10.3748/wjg.v19.i40.6784
Table 2 The list of next-generation sequencing-based studies of colorectal cancer genomes
Ref.NGS typesMajor findingsAlteration types and software used
Bass et al[16]WGS (9 pairs; tumor-matched normal)Oncogenic fusion (VTI1A-TCG7L2)Point mutations (MuTect[83])
Indels (Indelocator)1
Rearrangements (dRanger)1
TCGA consortiumWGS (97 pairs; low-pass)See main textPoint mutations (MuTect)
RNA-seq (218 tumors)Recurrent mutations (MutSig)1
Exome-seq (254 pairs)DNA copy numbers (BIC-seq[82])
Rearrangements (BreakDancer[81])
Timmermann et al[84]Exome-seq (2 pairs, one MSI-H and one MSS)Comparison of mutation spectrum between MSI-H and MSS CRC genomesPoint mutation and indel (Vendor-provided GS reference mapper, Roche)
Zhou et al[85]Exome-seq (1 series: normal-adenoma-adenocarcinoma)Comparison of benign and malignant CRC genomes in the same patientPoint mutation and indel (Samtools[86])
Kloosterman et al[73]WGS (4 pairs; primary-metastasis-matched normals)Targeted 1300 genes (4 pairs)Comparison of primary or metastatic CRC genomesChromothripsis and mutations (Burrow-Wheeler aligner[87] based in-house tools)
Brannon et al[88] (Proceedings)Targeted 230 genes (50 pairs: primary-metastasis-matched normals)Comparison of primary or metastatic CRC genomesIMPACT (integrated mutation profiling of actionable cancer targets)
Yin et al[89]RNA-seq (2 pairs)RNA-seq based mutation studyPoint mutations and indels (Samtools)